Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate and Ursodeoxycholic Acid in Primary Biliary Cholangitis
NCT06755151Phase 3Recruiting
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Jan 2024
- Primary completion
- Dec 2035
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenofibrate in primary biliary cholangitis (PBC), sponsored by Xijing Hospital of Digestive Diseases. Started Jan 2024; status: recruiting.
02
Drugs
fenofibrate
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT06755151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06755151.